Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature review

Introduction: Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad antifungal cover and favorable side effect profile but, notably, it has no activity...

Full description

Bibliographic Details
Main Authors: John R. Louis-Auguste, Christianne Micallef, Tim Ambrose, Sara Upponi, Andrew J. Butler, Dunecan Massey, Stephen J. Middleton, Neil Russell, Charlotte S. Rutter, Lisa M. Sharkey, Jeremy Woodward, Effrossyni Gkrania-Klotsas, David A. Enoch
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:IDCases
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250918300064